Showing 131-140 of 1346 results for "".
The Science Driving Topicals Into the Future
https://practicaldermatology.com/topics/psoriasis/the-science-driving-topicals-into-the-future/19721/On the therapeutic front, one topic Neal Bhatia, MD is paying particularly close attention to is recent advances in vehicle science, which offer novel and intriguing strategies to improve delivery of topical applications to and through the skin.Cosmeceuticals: It's All About End Results
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmeceuticals-it-s-all-about-end-results/18582/End results separate the science from the marketing of topical cosmetic products, says Annie Chiu, MD. She talks about the challenges of formulating and preserving delicate ingredients and explains why packaging is so important. Patients need education about ingredients and packaging, she says, to oClosing Gaps in Care for People of Color with Psoriatic Disease
https://practicaldermatology.com/programs/practical-dermatology/closing-gaps-in-care-for-people-of-color-with-psoriatic-disease/18190/Black, Hispanic, Asian, and other people of color with plaque psoriasis and psoriatic arthritis often face delayed diagnosis, misdiagnosis, and limited access to testing, treatment, and care. Determi-Nation, a new initiative sponsored by Janssen Pharmaceuticals, aims to change this. Patient advocateePrime
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/eprime/19381/Overview of the ePrime system for reduction in wrinkles and increase in foundational skin volume. The system uses precisely controlled radiofrequency delivery for energy-based dermal remodeling. Aspects of the system, its benefits, and impact on the practice are reviewed.DermWireTV: Practices Reopen; Prescriber's Choice Expands; Sun Takes on Acne
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-practices-reopen-prescribers-choice-expands-sun-takes-on-acne/19810/Dermatology practices across the US are re-opening and professional associations are offering guidance, as states reduce restrictions. From Prescriber's Choice comes PC Direct for in-office use and PC Delivers for remote prescribing. Sun Dermatology’s Take on Acne advertising campaign is raising awaHow Incyte Is Following the Science to Address Unmet Needs in Immune-Mediated Skin Conditions
https://practicaldermatology.com/topics/infections-infectious-disease/how-incyte-is-following-the-science-to-address-unmet-needs-in-immune-mediated-skin-conditions/19945/Ahmad Naim, MD, Vice President of US Medical Affairs at Incyte, shares how the company’s discovery expertise in immunology is fueling research aimed at delivering innovative medicines that address the unmet needs of people living with immune-mediated dermatologic conditions, including atopic dermatiDermWireTV: Clinical Support Tech Data; Dupixent, Stelara Updates; Rihanna Launches Fenty Skin
https://practicaldermatology.com/topics/psoriasis/dermwiretv-clinical-support-tech-data-dupixent-stelara-updates-rihanna-launches-fenty-skin/19835/A feasibility study in collaboration between LEO Innovation Lab, VisualDX, and the German Association of Dermatological Prevention supports technology to assist in diagnosis of skin conditions. Leo Pharma’s investigational JAK inhibitor delgocitinib cream is Fast Tracked by the FDA for the potentiaLaser hair removal in darker skin types, challenges and technological advances for treatment
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-hair-removal-in-darker-skin-types-challenges-and-technological-advances-for-treatment/18800/Andrew Alexis, MD discusses laser hair removal treatment challenges in patients with higher Fitzpatrick skin types, and how recent advances in technology have been able to address these to deliver effective treatment with minimal pain.A Practical Approach to Home UVB Phototherapy for the Treatment of Generalized Psoriasis
https://practicaldermatology.com/topics/psoriasis/a-practical-approach-to-home-uvb-phototherapy-for-the-treatment-of-generalized-psoriasis/21926/Specialists review the basics of choosing ideal patients for home UVB, delineate key aspects of patient education, and provide detailed information on currently available phototherapy equipment.Phio Pharmaceuticals Takes Aim at Skin Cancer
https://practicaldermatology.com/series/c-suite-chats/phio-pharmaceuticals-takes-aim-skin-cancer/24316/In the first episode of Practical Dermatology's C-Suite Chats, Robert Bitterman, CEO of Phio Pharmaceuticals, discusses the company's patented INTASYL technology. Learn more about this platform for creating and delivering uniquely modified siRNA compounds to treat cancer.